Clinical Trial Update: Safety and Efficacy of Treatment With Interferon Beta-1a Rebif® in Patients With Crohn's Disease [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating interferon beta-1a (Rebif) for Crohn's disease was terminated. The update covers safety and efficacy results from the trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Rebif (interferon beta-1a)

Snippet

Sponsor: EMD Serono | Conditions: Crohn's Disease | Phase 2 | Status: TERMINATED